(Reuters) -CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround ...

CVS Health announced on Monday that it struck a deal with dissident investor Glenview Capital for four board seats, just a few weeks after the health-care giant ousted former CEO Karen Lynch. Glenview ...

NEW YORK, Oct. 18, 2024 /PRNewswire/ -- Earlier, Glenview and CVS executed a Non-Disclosure Agreement to facilitate the good faith exchange of information and perspectives and discussions commenced.

Investing.com -- Shares of CVS Health (NYSE:CVS) rose 2.8% in premarket trading on Monday following a report from the Wall Street Journal that the company will expand its board as part of an agreement ...

CVS Health (NYSE:CVS) investor Glenview Capital has denied reports that it is pushing for a breakup of the company, asserting that it has been engaged in “good faith and constructive conversations” ...

NEW YORK (Reuters) - Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing bets and established a new position during the third ...

Hedge fund Glenview Capital Management is set to meet with top executives at CVS Health on Monday to propose operational improvements, The Wall Street Journal reported, citing people with knowledge of ...

NEW YORK, May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total ...

CVS Health struck a deal with dissident Glenview Capital, giving the investor four board seats. Glenview had been pushing for changes at the health-care giant and had met with former CEO Karen Lynch ...